A nurse is providing care for several clients who have type 2 diabetes mellitus. Which of the following clients is most at risk for developing hyperosmolar hyperglycemic syndrome (HHS)?

Choice A reason: Acetone Breath

Acetone breath is typically associated with diabetic ketoacidosis (DKA), not hyperosmolar hyperglycemic syndrome (HHS). In DKA, the body produces high levels of ketones, leading to a fruity or acetone-like breath odor. HHS, on the other hand, does not usually involve significant ketone production, so acetone breath is not a characteristic feature of HHS.

Choice B reason: Fever

Fever can be a clinical manifestation of HHS, often indicating an underlying infection, which is a common precipitating factor for HHS. Infections can exacerbate hyperglycemia and contribute to the development of HHS, making fever a relevant symptom to consider.

Choice C reason: 68 Years of Age

While age itself is not a clinical manifestation, HHS predominantly affects older adults, particularly those with type 2 diabetes. Therefore, being 68 years old is consistent with the typical demographic affected by HHS, but it is not a direct clinical manifestation.

Choice D reason: Serum Glucose 800 mg/dL

A serum glucose level of 800 mg/dL is significantly elevated and is a hallmark of HHS2. Normal serum glucose levels range from 74 to 106 mg/dL. Such high levels of glucose are indicative of severe hyperglycemia, which is a defining characteristic of HHS.

Choice E reason: Serum Bicarbonate 15 mEq/L

A serum bicarbonate level of 15 mEq/L is below the normal range of 21 to 28 mEq/L. This indicates metabolic acidosis, which can occur in HHS due to severe dehydration and impaired renal function. Although metabolic acidosis is more pronounced in DKA, it can still be present in HHS.

Choice F reason: Insidious Onset

HHS typically has an insidious onset, developing slowly over days to weeks. This gradual progression contrasts with the rapid onset of DKA and is a key feature in the clinical presentation of HHS.

Choice A reason:

Injections in the thigh are absorbed more slowly compared to the abdomen. The thigh is a common site for insulin injections, but it does not provide the fastest absorption rate. The absorption rate can be influenced by physical activity, as exercise can increase blood flow to the muscles, potentially speeding up insulin absorption. However, under normal conditions, the thigh is not the fastest site for insulin absorption.

Choice B reason:

Injections in the upper arm have a moderate absorption rate. The upper arm is another common site for insulin injections, but it is not the fastest. The absorption rate from the upper arm is generally faster than the thigh but slower than the abdomen. This site can be convenient for injections, especially for those who find it difficult to reach other areas.

Choice C reason:

Injections in the buttocks have the slowest absorption rate among the common injection sites. The buttocks are less commonly used for insulin injections due to the slower absorption rate and the difficulty some individuals may have in administering injections in this area. The high fat content in the buttocks slows down the absorption of insulin.

Choice D reason:

Injections in the abdomen provide the fastest absorption rate for insulin. The abdomen is the preferred site for many people with diabetes because it has a large surface area and is easy to access. The insulin injected into the abdominal area is absorbed quickly into the bloodstream, making it the most effective site for rapid-acting insulin. This is particularly important for managing blood sugar levels around meal times.